{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-23-000041","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.891078+00:00","generated_at":"2026-06-14T18:27:27.930637+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Maravai LifeSciences shareholders elect three Class III directors at 2023 annual meeting","bullets":["Anat Ashkenazi, Gregory T. Lucier, and Luke Marker elected as Class III directors with over 183M votes each.","Ratification of Ernst & Young as independent auditor for 2023 passed with 234,840,684 votes for, 15,103 against.","Non-binding advisory vote on executive compensation approved: 221,869,456 for, 8,907,696 against.","Quorum present: 234,865,441 of 250,882,769 outstanding shares, representing approximately 93.6%."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-23-000041","json":"https://secwatch.observer/filing/0001823239-23-000041.json","markdown":"https://secwatch.observer/filing/0001823239-23-000041.md","text":"https://secwatch.observer/filing/0001823239-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/0001823239-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/mrvi-20230518.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:27:27.930637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13fc1ed6f0e3dc95ae39a0f28810f7ab19a1887c","claim":"MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers at the 2023-05-18 meeting.","evidence_excerpt":"Proposal No. 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's Proxy Statement for the Annual Meeting. Votes For Votes Against Abstentions Broker Non-Votes 221,869,456 8,907,696 27,642 4,060,647","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/0001823239-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-18"}],"fact_type":"shareholder_vote"},{"claim_id":"2d2c33507387f477fe348f50a71690de9645313d","claim":"MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Election of directors at the 2023-05-18 meeting.","evidence_excerpt":"Proposal No. 1: Election of directors. The Company’s shareholders elected the following nominees for director to serve as Class III directors for a three-year term expiring at the Company’s 2026 annual meeting of shareholders and until their successors are duly elected and qualified. Nominee Votes For Votes Withheld Broker Non-Votes Anat Ashkenazi 186,578,234 44,226,560 4,060,647 Gregory T. Lucier 186,046,648 44,758,145 4,060,648 Luke Marker 183,198,145 47,606,648 4,060,648","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/0001823239-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-18"}],"fact_type":"shareholder_vote"},{"claim_id":"49aadcb89561a166e7700e8ad0055586f1d4aee2","claim":"MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-05-18 meeting.","evidence_excerpt":"Proposal No. 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 was ratified. Votes For Votes Against Abstentions 234,840,684 15,103 9,654","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/0001823239-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-18"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}